Skarda J, Köhlerová E
Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, Vídenská 1083, 142 20 Prague 4, Czech Republic.
J Vet Med A Physiol Pathol Clin Med. 2006 Apr;53(3):145-53. doi: 10.1111/j.1439-0442.2006.00805.x.
This study tested and compared the anti-proliferative and proliferative activities of two anti-oestrogens and three anti-progestins on four separate mouse model systems: young intact and adult ovariectomized (OV-X) females, and young intact and adult castrated males. Pure steroidal anti-oestrogen ICI 182,780 (ICI) decreased mammary and uterine growth stimulated by endogenous hormones in young intact females and by exogenous hormones [progesterone (Prog), 17beta-oestradiol (E) or E plus Prog] in both young intact and adult ovariectomized (OV-X) females. Non-steroidal anti-oestrogen EM-800 (EM), on the other hand, had no effect on mammary and uterine growth stimulated by endogenous hormones in young intact females and in adult OV-X females. Uterine growth was even stimulated by EM alone, and a combination of EM plus Prog not only stimulated uterine growth but also mammary growth (an oestrogenic agonistic activity). However, EM showed anti-oestrogenic activities in both mammary and uterine tissues in females treated with E or E plus Prog. In males, ICI and EM decreased mammary growth stimulated by exogenous hormones (E or E plus Prog) in both young intact and adult castrated animals. In young intact, but not in adult castrated males, ICI increased seminal vesicle growth affected by both endogenous and exogenous (Prog, E or E plus Prog) hormones. EM, on the other hand, decreased seminal vesicle weights in E or E plus Prog and increased its weights in Prog-treated young intact males. Thus, under certain conditions EM possess mixed agonist and antagonist activity in the mammary gland, uterus and seminal vesicles. Norethindrone acetate (NA)-stimulated mammary growth was decreased by anti-progestins onapristone (ON), RU 46556 (RU), and RU 38486 (MI) by 34-59% in females and by 35-93% in males. Uterine weights of NA-treated females were decreased by ON and RU by 29-55% but not by MI. In NA-treated young intact males, seminal vesicle weights were stimulated by RU (by 63%) and not affected by ON and MI. In NA-treated adult castrated males, seminal vesicle weights were decreased by ON, increased by RU and not affected by MI. The results obtained in these and our earlier studies show clearly that mouse four-model systems could serve as in vivo tool for the detection of steroid hormone agonist and antagonist activities of natural and man-made chemicals.
年轻未阉割和成年去卵巢(OV-X)雌性小鼠,以及年轻未阉割和成年去势雄性小鼠。纯甾体抗雌激素ICI 182,780(ICI)可降低年轻未阉割雌性小鼠体内内源性激素以及年轻未阉割和成年去卵巢(OV-X)雌性小鼠体内外源性激素[孕酮(Prog)、17β-雌二醇(E)或E加Prog]刺激的乳腺和子宫生长。另一方面,非甾体抗雌激素EM-800(EM)对年轻未阉割雌性小鼠和成年OV-X雌性小鼠体内内源性激素刺激的乳腺和子宫生长没有影响。单独使用EM甚至可刺激子宫生长,EM与Prog联合使用不仅可刺激子宫生长,还可刺激乳腺生长(一种雌激素激动活性)。然而,在接受E或E加Prog治疗的雌性小鼠的乳腺和子宫组织中,EM均表现出抗雌激素活性。在雄性小鼠中,ICI和EM均可降低年轻未阉割和成年去势动物体内外源性激素(E或E加Prog)刺激的乳腺生长。在年轻未阉割但成年去势雄性小鼠中,ICI可增加受内源性激素和外源性激素(Prog、E或E加Prog)影响的精囊生长。另一方面,EM可降低E或E加Prog处理的年轻未阉割雄性小鼠的精囊重量,并增加Prog处理的年轻未阉割雄性小鼠的精囊重量。因此,在某些条件下,EM在乳腺、子宫和精囊中具有混合激动剂和拮抗剂活性。醋酸炔诺酮(NA)刺激的乳腺生长在雌性小鼠中被抗孕激素奥那司酮(ON)、RU 46556(RU)和RU 38486(米非司酮,MI)降低了34%-59%,在雄性小鼠中降低了35%-93%。接受NA治疗的雌性小鼠的子宫重量被ON和RU降低了29%-55%,但未被MI降低。在接受NA治疗的年轻未阉割雄性小鼠中,RU刺激了精囊重量(增加了63%),而ON和MI未对其产生影响。在接受NA治疗的成年去势雄性小鼠中,ON降低了精囊重量,RU增加了精囊重量,MI未对其产生影响。在这些研究以及我们早期研究中获得的结果清楚地表明,小鼠四模型系统可作为检测天然和人造化学物质类固醇激素激动剂和拮抗剂活性的体内工具。